LRRK2 and Parkinson disease: In this context, it has been shown that cellular senescence is promoted via the upregulation of the p53/p21 pathway due to the G2019S most prevalent LRRK2 mutation, which, through an increase of its activity further, accelerates α-synuclein aggregation and contributes to PD progression [445].